• Home
  • Science
    • ImmunoBody®
    • Moditope®
    • Glymab®
    • Publications
  • Pipeline
  • News
  • Investors
    • Share Info
    • Financial Info
    • Documents & Presentations
    • Corporate Governance
  • Contact Us
    • Find a trial
    • Become an Investigator

Annual Meeting of the American Society of Clinical Oncology (ASCO), 2 – 6 June 2023 in Chicago, Illinois, USA

by admin | Jun 3, 2023 | Moditope, Vaccines

Christian Ottensmeier, David J Pinato, Rebecca Herbertson, Anne Armstrong, Stefan Symeonides, Poulam Patel, Sarah J Danson, James Korolewicz, David Cameron, Robert Miller, Fayaz Master, Samantha Paston, Lindy Durrant

SARS-Cov-2 Spike RBD and Nucleocapsid Encoding DNA Vaccine Elicits T cell and Neutralising Antibody Responses that Cross React with Variants

by admin | May 26, 2023 | Immunobody, Vaccines

Brentville VA, Vankemmelbeke M, Metheringham RL, Symonds P, Cook KW, Urbanowicz RA, Tsoleridis T, Coleman CM, Chang K-C, Skinner A, Dubinina E, Daniels I, Shah S, Argonza M, Delgado J, Dwivedi V, Kulkarni V, Dixon JE, Pockley AG, Adams SE, Paston SJ, Daly JM, Ball JK,...

*PDF*Annual Meeting of The American Association for Cancer Research (AACR), 14 – 19 April 2023 in Orlando, Florida, USA

by admin | Apr 18, 2023 | Moditope, Vaccines

Lindy Durrant, Fayaz Master, Samantha Paston, Robert Miller, David J Pinato, Rebecca Herbertson, Anne Armstrong, Stefan Symeonides, Christian Ottensmeier

Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool

by admin | Apr 17, 2023 | Moditope, Vaccines

Ruhul H. Choudhury, Ian Daniels, Poonam Vaghela, Suha Atabani, Thomas Kirk, Peter Symonds, Katherine W. Cook, Abdullah Al-Omari, Daisy Weston, Sabaria Shah, David Hutchinson, Samantha J. Paston, Rachael L. Metheringham, Victoria A. Brentville, Lindy G. Durrant...

Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy

by admin | Dec 9, 2022 | Moditope, Vaccines

Victoria Anne Brentville, Peter Symonds, JiaXin Chua, Anne Skinner, Ian Daniels, Katherine Wendy Cook, Sasa Koncarevic, Roxana Martinez-Pinna, Sabaria Shah, Ruhul Hasan Choudhury, Poonam Vaghela, Daisy Weston, Abdullah Al-Omari, James Davis and Lindy G. Durrant...

37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), 8-12 November 2022 in Boston, MA, USA

by admin | Nov 6, 2022 | Moditope, Vaccines

V Brentville, P Symonds, J Chua, A Skinner, I Daniels, K Cook, S Koncarevic, R Martinez-Pinna, S Shah, RH Choudhury, P Bilimoria1, D Weston, A Al-Omari, J Davis and L Durrant
« Older Entries
Next Entries »

Recent Posts

  • Active Immunotherapy: Ready For Prime Time
  • Strategic transactions to unlock longer-term value
  • Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
  • iSCIB1+ pivotal trial plans advancing
  • AACR (American Association for Cancer Research) Annual Meeting, April 2026, San Diego, California

Recent Comments

No comments to show.

Scancell is focused on developing novel immunotherapies for the treatment of cancer and was founded in 1996 based on research led by Professor Lindy Durrant at the University of Nottingham in the UK.

  • Follow
  • Follow

Science
Our Pipeline
News
Contact Us
Find a Trial
Become an Investigator

ACTIVE IMMUNOTHERAPY

ImmunoBody®
Moditope®

ANTIBODIES

GlyMab®
AvidiMab®

Investors
Company Profile
Advisors
Corporate Governance
Documents & Presentations
Share Information
Financial Information

Copyright © 2026 Scancell | Website Designed & Developed by Identity Creative | Privacy & Cookie Policy